```html

Yellowish Scleral Discoloration

What is Yellowish Scleral Discoloration?

The sclera is the white, dense outer coating of the eye that gives the eyeball its shape and protects its inner structures. When the sclera takes on a yellowish tint, the condition is commonly referred to as jaundice of the eye or “yellow sclera.” This discoloration happens because of an excess of bilirubin—a yellow pigment formed from the normal breakdown of red blood cells—depositing in the connective tissue of the sclera. Because the sclera is highly vascular and thin, it can reflect changes in bilirubin levels faster than the skin, often serving as an early visual cue for systemic disease.

Yellow sclera is not a disease itself; rather, it is a sign that something else is happening in the body. The degree of discoloration can range from a faint straw‑colored hue to a deep amber tone. In most cases, the underlying cause is benign and reversible, but some etiologies require urgent medical attention.

Common Causes

Below are the most frequent conditions that can produce a yellowish scleral hue. Many of these disorders affect bilirubin metabolism, liver function, or red‑blood‑cell turnover.

• Hepatitis (A, B, C, or alcohol‑related) – Inflammation of liver cells impairs bilirubin clearance.
• Alcoholic liver disease & cirrhoscrosis – Chronic alcohol use damages hepatocytes, leading to cholestasis.
• Gilbert’s syndrome – A benign, inherited reduction in the enzyme glucuronyl‑transferase, causing intermittent mild hyperbilirubinemia.
• Hemolytic anemia – Accelerated breakdown of red blood cells releases large amounts of bilirubin.
• Obstructive (cholestatic) jaundice – Gallstones, bile‑duct strictures, or pancreatic cancer block bile flow.
• Newborn physiological jaundice – Immature liver enzymes in the first week of life; the sclera can turn yellow before the skin.
• Drug‑induced liver injury – Acetaminophen overdose, certain antibiotics (e.g., amoxicillin‑clavulanate), or antiretrovirals.
• Autoimmune hepatitis – The body attacks liver tissue, impairing bilirubin processing.
• Primary biliary cholangitis (PBC) – An autoimmune disease that damages the small bile ducts.
• Severe infection or sepsis – Can cause transient cholestasis and mild jaundice.

Associated Symptoms

Yellow sclera almost always accompanies other signs of elevated bilirubin or liver dysfunction. The specific constellation of symptoms depends on the underlying cause:

• Skin or nail discoloration (jaundice) – Often follows scleral yellowing.
• Dark urine – Bilirubin excreted in urine gives it a tea‑colored appearance.
• Pale, tar‑colored stools – Decreased bile pigment reaching the intestines.
• Itching (pruritus) – Bile salts deposited in the skin.
• Upper‑right abdominal pain or fullness – Possible liver or gallbladder pathology.
• Fatigue, weakness, or malaise – Common in chronic liver disease.
• Nausea, vomiting, or loss of appetite – Especially with hepatitis or biliary obstruction.
• Fever and chills – May indicate infection or cholangitis.
• Weight loss or night sweats – Red flags for malignancy (e.g., pancreatic cancer).

When to See a Doctor

Because yellow sclera can be the first external sign of a serious systemic problem, prompt evaluation is important. Seek medical care if you notice any of the following:

• Yellowing that persists more than 2–3 days or worsens.
• Accompanying skin jaundice, especially if it spreads to the chest or abdomen.
• Dark urine, pale stools, or severe itching.
• Upper‑right abdominal pain, especially after meals.
• Unexplained weight loss, night sweats, or fever.
• History of liver disease, alcohol misuse, recent travel to hepatitis‑endemic areas, or exposure to toxins.
• In infants, yellowing of the sclera that does not fade within the first two weeks of life.

Diagnosis

Evaluation of yellow scleral discoloration follows a systematic approach to uncover the underlying cause.

1. Clinical History & Physical Examination

• Duration and progression of discoloration.
• Alcohol consumption, medication use, recent infections, family history of liver disease.
• Full physical exam focusing on liver size, tenderness, and signs of chronic liver disease (spider angiomas, palmar erythema, ascites).

2. Laboratory Tests

• Serum bilirubin (total and direct) – Determines if the bilirubin is conjugated (cholestatic) or unconjugated (hemolytic or metabolic).
• Liver enzymes: ALT, AST, ALP, GGT – Help differentiate hepatocellular vs. cholestatic patterns.
• Complete blood count (CBC) – Looks for hemolysis (low hemoglobin, high reticulocyte count).
• Coagulation profile (PT/INR) – Assesses liver synthetic function.
• Viral hepatitis serologies (HBsAg, anti‑HBc, anti‑HCV).
• Autoimmune markers (ANA, ASMA, anti‑LKM) if autoimmune hepatitis is suspected.
• Iron studies, ceruloplasmin (for hemochromatosis or Wilson disease) when appropriate.

3. Imaging Studies

• Abdominal ultrasound – First‑line to evaluate liver size, gallbladder, bile ducts, and detect stones or masses.
• CT or MRI abdomen – Provides detailed anatomy if ultrasound is inconclusive.
• MRCP (magnetic resonance cholangiopancreatography) – Non‑invasive view of the biliary tree for strictures or tumors.

4. Specialized Tests

• Liver biopsy – Rare, reserved for unexplained chronic liver disease.
• Hemolysis work‑up (haptoglobin, LDH, peripheral smear) – When unconjugated bilirubin is high.
• Genetic testing for Gilbert’s syndrome (UGT1A1 variant) – Typically only for persistent, mild cases.

Treatment Options

Treatment is directed at the underlying cause; the scleral color usually normalizes as bilirubin levels fall. Below are general strategies.

1. Addressing Liver Disease

• Viral hepatitis – Antiviral therapy (e.g., direct‑acting antivirals for HCV, tenofovir or entecavir for HBV).
• Alcoholic liver disease – Complete abstinence from alcohol, nutritional support, and possibly steroids for alcoholic hepatitis.
• Autoimmune hepatitis – Corticosteroids (prednisone) +/- azathioprine.
• Primary biliary cholangitis – Ursodeoxycholic acid; second‑line obeticholic acid if needed.

2. Managing Obstructive Jaundice

• Endoscopic removal of gallstones (ERCP) or placement of a biliary stent.
• Surgical resection for tumors obstructing the bile duct.

3. Treating Hemolysis

• Stop offending drugs (e.g., certain antibiotics).
• Treat underlying hemolytic disorder (e.g., corticosteroids for autoimmune hemolytic anemia, chelation for sickle cell disease).

4. Supportive & Home Care

• Hydration – Adequate fluids help the liver flush bilirubin.
• Balanced diet rich in fruits, vegetables, lean protein, and low in saturated fat.
• Avoid excessive alcohol and hepatotoxic substances.
• Phototherapy – Primarily for newborns with severe jaundice.
• Vitamin K supplementation if clotting factors are low (under physician guidance).

5. Monitoring

Regular follow‑up labs to track bilirubin, liver enzymes, and clinical status are essential. Most patients see improvement within 1–2 weeks of effective therapy; persistent discoloration warrants re‑evaluation.

Prevention Tips

While some causes (genetic conditions) cannot be prevented, many risk factors are modifiable.

• Limit alcohol intake – No more than one drink per day for women, two for men.
• Follow safe medication practices: read labels, avoid unnecessary over‑the‑counter acetaminophen, and discuss liver‑impacting drugs with your doctor.
• Vaccinate against hepatitis A and B.
• Practice safe sex and avoid sharing needles to reduce hepatitis C risk.
• Maintain a healthy weight and exercise regularly to prevent non‑alcoholic fatty liver disease (NAFLD).
• Eat a diet high in fiber, antioxidants, and omega‑3 fatty acids; limit processed foods and excess sugars.
• Stay hydrated and get adequate sleep to support liver regeneration.
• For infants, ensure early pediatric visits; treat newborn jaundice promptly with phototherapy if needed.

Emergency Warning Signs

If you experience any of the following, seek emergency care (ER or call 911) immediately. These signs may indicate life‑threatening complications such as acute liver failure, cholangitis, or severe hemolysis.

• Sudden, severe abdominal pain in the upper right quadrant with fever and chills.
• Confusion, drowsiness, or sudden difficulty waking up (possible hepatic encephalopathy).
• Rapidly worsening jaundice accompanied by vomiting blood or passing black stools (GI bleeding).
• Shortness of breath or rapid heart rate with pale or jaundiced skin (severe hemolysis or sepsis).
• Unexplained swelling of the abdomen (ascites) or sudden weight gain.
• Persistent vomiting, especially if unable to keep fluids down.

---

**References**

• Mayo Clinic. “Jaundice.” https://www.mayoclinic.org
• Cleveland Clinic. “Yellowing of the Eyes (Scleral Icterus).” https://my.clevelandclinic.org
• National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “Liver Disease.” https://www.niddk.nih.gov
• World Health Organization. “Hepatitis Fact Sheet.” https://www.who.int
• American College of Gastroenterology. “Guidelines for the Diagnosis and Management of Cholestatic Liver Disease.” Gastroenterology, 2022.

```